Therefore, we hypothesize that in the absence of PLIN5, a decrease in PGC-1α and possibly its downstream targets leads to reduced levels of CPT1 in Plin5−/− mice in NAFLD. The gene discussed is PLIN5; the disease is metabolic dysfunction-associated steatotic liver disease.